Symbols

ELUT

Elutia·NASDAQ

--(--)

ELUT Profile

Elutia Inc.

A commercial-stage regenerative medicine company that develops regenerative medical products for patients undergoing surgery and receives implantable devices

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

10/08/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.elutia.com

Security Type

Common stock

Office address

20 Firstfield Road Gaithersburg MD 20878

Business

Introduction

Elutia Inc., was incorporated in Delaware in August 2015. The company develops proprietary drug-eluting biological matrix products for surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. The company's focus is on addressing unmet medical needs and reducing surgery-related complications, including infection, migration, erosion, implant rejection and fibrosis. The company operates across R&D through the commercial distribution of bio-matrix products for plastic and reconstructive surgery.